Insulinomas are rare gastrointestinal tumors with an incidence of 1-3 per million inhabitants annually. These tumors result in excessive insulin production, culminating in hypoglycemia. Such hypoglycemia triggers various central nervous system (CNS) manifestations, including headache, confusion, abnormal behavior, and epileptic seizures, which can lead to misdiagnosis as epilepsy. This case report documents a 46-year-old male who presented seizure-like episodes. Episodes occurred mainly during the night, lasting several minutes to hours. Initial seizures were characterized by bizarre behavior and altered responsiveness. Over time, seizure frequency, complexity, and severity escalated. We managed to record two episodes during long-term EEG and report, as the first ones, the detailed quantitative EEG analysis of these hypoglycemia-related events. EEG changes preceded the development of clear-cut pathological motor activity in tens of minutes and were present in all investigated frequency bands. The development of profound motor activity was associated with other increases in EEG power spectra in all frequencies except for delta. The most pronounced changes were found over the left temporal region, which can be the most susceptible to hypoglycemia. In our patient, the seizure-like episodes completely disappeared after the insulinoma removal, which demonstrates their relationship to hypoglycemia.

1st Department of Neurology St Anne's University Hospital Brno Masaryk University Member of the ERN EpiCARE Brno Czechia

Department of Neurosurgery University Hospital Brno Brno Czechia

Faculty of Medicine Masaryk University Brno Czechia

Institute of Scientific Instruments of the CAS Brno Czechia

See more in PubMed

Mehrabi A, Fischer L, Hafezi M, Dirlewanger A, Grenacher L, Diener MK, et al. . A systematic review of localization, surgical treatment options, and outcome of insulinoma. Pancreas. (2014) 43:675–86. doi: 10.1097/MPA.0000000000000110, PMID: PubMed DOI

Pieterman CRC, van Leeuwaarde RS, van den Broek MFM, van Nesselrooij BPM, Valk GD. Multiple endocrine neoplasia type 1 In: Feingold KR, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E, et al., editors. Endotext. South Dartmouth, MA: MDText.com, Inc. (2000)

Hofland J, Kaltsas G, de Herder WW. Advances in the diagnosis and Management of Well-Differentiated Neuroendocrine Neoplasms. Endocr Rev. (2020) 41:371–403. doi: 10.1210/endrev/bnz004, PMID: PubMed DOI PMC

Auer RN. Hypoglycemic brain damage. Forensic Sci Int. (2004) 146:105–10. doi: 10.1016/j.forsciint.2004.08.001 PubMed DOI

Deleo F, Matricardi S, Didato G, Montano N, Gnatkovsky V, Romito LM, et al. . An unusual behavioural and motor paroxysmal disorder caused by insulinoma-related hypoglycemia: a possible cause of epilepsy misdiagnosis. Seizure. (2014) 23:909–11. doi: 10.1016/j.seizure.2014.06.018, PMID: PubMed DOI

Marks V. Progress report. Diagnosis of insulinoma. Gut. (1971) 12:835–43. PMID: PubMed PMC

Dudley A, Khalil MI, Mullins G, Delanty N, Naggar HE. Hypoglycaemic events resembling focal seizures-a case report and literature review. Seizure. (2022) 94:10–7. doi: 10.1016/j.seizure.2021.11.002, PMID: PubMed DOI

Mauritz M, Hirsch LJ, Camfield P, Chin R, Nardone R, Lattanzi S, et al. . Acute symptomatic seizures: an educational, evidence-based review. Epileptic Disord. (2022) 24:26–49. doi: 10.1684/epd.2021.1376, PMID: PubMed DOI

Lowe RN, Williams B, Claus LW. Diabetes: how to manage patients experiencing hypoglycaemia. Drugs. Context. (2022) 11:2021-9–11. doi: 10.7573/dic.2021-9-11, PMID: PubMed DOI PMC